1. Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics
   Shuchan Li et al, 2022, Cell Biology and Toxicology CrossRef
2. Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
   Jianmin Chen et al, 2015, Biochemistry Insights CrossRef
3. Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
   Bharti Badhani et al, 2015, RSC Advances CrossRef
4. Imaging Biomarkers in Animal Models of Drug-Induced Lung Injury: A Systematic Review
   Irma Mahmutovic Persson et al, 2020, Journal of Clinical Medicine CrossRef
5. Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions
   Rui Shao et al, 2019, Frontiers in Pharmacology CrossRef
6. Pathogenic substantiation of application of erythropoietin modified forms and peptide analogues as cytotprotectors
   Igor Ivanov et al, 2020, Pharmacy Formulas CrossRef
7. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
   Jorge Soliz et al, 2020, Respiratory Physiology & Neurobiology CrossRef